KEDI Global Longevity Bio Index

The index is designed to offer targeted long exposure to companies that are most significantly aligned with three high-impact themes within the healthcare sector: 'Obesity Drug,' 'Alzheimer Drug,' and 'Artificial Intelligence' (AI). These areas represent dynamic and transformative sectors, driving groundbreaking advancements in healthcare and technology. The development of innovative obesity and Alzheimer treatments addresses urgent global health challenges, while artificial intelligence continues to revolutionize industries and unlock new economic opportunities. To identify the companies leading in these fields, Akros employs its proprietary Large Language Model (LLM) technology to identify a focused portfolio of industry leaders and innovators to reap benefit from the growth and breakthroughs in these transformative areas.